Mayo Clinic news - Researchers at Mayo Clinic’s campus in Jacksonville and Virginia Tech in Blacksburg, Va., through their technology commercialization efforts, have licensed compounds to AstraZeneca for potential new drug therapies to treat depression. The collaboration advances both the development of novel compounds and supports ongoing research by Mayo and Virginia Tech in the [...]
AP - Drugmaker AstraZeneca PLC said Monday it launched its drug Seroquel XR as a treatment for bipolar disorder in addition to a previous approval for schizophrenia.
The London-based company will sell Seroquel XR as a treatment for depressive, manic and mixed episodes of bipolar I disorder, as well as schizophrenia in adults, and acute schizophrenic [...]
Mayo Clinic release - Researchers at Mayo Clinic’s campus in Jacksonville and Virginia Tech in Blacksburg, Va., through their technology commercialization efforts, have licensed compounds to AstraZeneca for potential new drug therapies to treat depression. The collaboration advances both the development of novel compounds and supports ongoing research by Mayo and Virginia Tech in the [...]
Reuters - A widely available blood pressure pill could one day help people erase bad memories, perhaps treating some anxiety disorders and phobias, according to a Dutch study published on Nature Neuroscience.
The generic beta-blocker propranolol significantly weakened people’s fearful memories of spiders among a group of healthy volunteers who took it, said Merel Kindt, a [...]
Press release - Alkermes, Inc. announced that the Food and Drug Administration (FDA) has asked Alkermes’ partner, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), for additional information regarding the supplemental New Drug Application (sNDA) for RISPERDAL® CONSTA® ((risperidone) Long-Acting Injection). The sNDA, submitted in April 2008, sought approval for RISPERDAL CONSTA for adjunctive [...]
